Achieve Life Sciences Inc(ACHV-Q)NASDAQ
Today's Change
Real-Time Last Update
After Hours Change
After Hours Last Update
Volume
Latest News
Achieve Life Sciences Reports Financial Results for Third Quarter and Provides Corporate Update
GlobeNewswire - Thu Nov 9, 3:00PM CST
GlobeNewswire
Thu Nov 9, 3:00PM CST
Achieve Life Sciences Reports Financial Results for Second Quarter 2023 and Provides Corporate Update
GlobeNewswire - Mon Aug 14, 3:00PM CDT
GlobeNewswire
Mon Aug 14, 3:00PM CDT
Achieve Life Sciences Announces Publication of Cytisinicline Phase 3 ORCA-2 Smoking Cessation Trial in Journal of the American Medical Association (JAMA)
GlobeNewswire - Tue Jul 11, 10:23AM CDT
GlobeNewswire
Tue Jul 11, 10:23AM CDT
Short sales on the TSX: What bearish investors are betting against
The Globe and Mail - Fri Feb 24, 9:05AM CST
The Globe and Mail
Fri Feb 24, 9:05AM CST
Investors continue to target several sectors, including cannabis, banking, cryptocurrencies, electric vehicles and biotech
Achieve Life Sciences to Announce Second Quarter Financial Results and Host Conference Call and Webcast on August 11, 2022
Globe Newswire - Thu Jul 28, 2022
Globe Newswire
Thu Jul 28, 2022
SEATTLE and VANCOUVER, British Columbia, July 28, 2022 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a late-stage clinical...
Achieve Life Sciences Announces Granting of New Hire Inducement Awards
Globe Newswire - Fri Jul 1, 2022
Globe Newswire
Fri Jul 1, 2022
SEATTLE and VANCOUVER, British Columbia, July 01, 2022 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical...
Achieve Life Sciences Announces Participation at H.C. Wainwright 1st Annual Mental Health Conference
Globe Newswire - Tue Jun 21, 2022
Globe Newswire
Tue Jun 21, 2022
SEATTLE and VANCOUVER, British Columbia, June 21, 2022 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a late-stage clinical...
Achieve Life Sciences Announces Participation at LD Micro Invitational Conference
Globe Newswire - Thu May 26, 2022
Globe Newswire
Thu May 26, 2022
SEATTLE and VANCOUVER, British Columbia, May 26, 2022 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical...
36 of the Best Ideas Companies to Present at the Spring into Action - Best Ideas Investor Conference on May 16th - 20th, 2022
AccessWire - Mon May 16, 2022
AccessWire
Mon May 16, 2022
RALEIGH, NC / ACCESSWIRE / May 16, 2022 / The Spring into Action- Best Ideas Virtual Investor Conference will take place on May 16th - 20th, 2022, where 36 SmallCap, MicroCap and NanoCap public companies will be presenting via virtual webcast to a...
Achieve Life Sciences Announces Participation at Best Ideas Virtual Investor Conference
Globe Newswire - Fri May 13, 2022
Globe Newswire
Fri May 13, 2022
SEATTLE and VANCOUVER, British Columbia, May 13, 2022 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical...
Achieve Reports Financial Results for First Quarter 2022 and Provides Corporate Update
Globe Newswire - Thu May 12, 2022
Globe Newswire
Thu May 12, 2022
Company to host conference call at 4:30 PM EDT today, May 12, 2022...
Achieve Life Sciences to Announce First Quarter Financial Results and Host Conference Call and Webcast on May 12, 2022
Globe Newswire - Thu Apr 21, 2022
Globe Newswire
Thu Apr 21, 2022
SEATTLE and VANCOUVER, British Columbia, April 21, 2022 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical...
Achieve Life Sciences Announces Appointment of Dr. Vaughn Himes to Board of Directors
Globe Newswire - Mon Mar 14, 2022
Globe Newswire
Mon Mar 14, 2022
SEATTLE and VANCOUVER, British Columbia, March 14, 2022 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical...
Achieve Life Sciences Announces Expansion of Manufacturing & Quality Operations Team and Granting of Inducement Award
Globe Newswire - Fri Mar 11, 2022
Globe Newswire
Fri Mar 11, 2022
SEATTLE and VANCOUVER, British Columbia, March 11, 2022 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical...
Achieve Life Sciences Reports Financial Results for Fourth Quarter and Year-End 2021 and Provides Corporate Update
Globe Newswire - Thu Mar 10, 2022
Globe Newswire
Thu Mar 10, 2022
Company to host conference call at 4:30 PM EST today, March 10, 2022...
Achieve Life Sciences Announces Participation in March Investor Conferences
Globe Newswire - Tue Mar 8, 2022
Globe Newswire
Tue Mar 8, 2022
SEATTLE, Wash. and VANCOUVER, British Columbia, March 08, 2022 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage...
Achieve Life Sciences Announces Participation in February Investor Conferences
Globe Newswire - Wed Feb 2, 2022
Globe Newswire
Wed Feb 2, 2022
SEATTLE and VANCOUVER, British Columbia, Feb. 02, 2022 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical...
36 of the Best Ideas Companies to Present at the 2nd Annual Winter Wonderland Virtual Investor Conference on February 8th - 11th, 2022
AccessWire - Fri Jan 28, 2022
AccessWire
Fri Jan 28, 2022
RALEIGH, NC / ACCESSWIRE / January 28, 2022 / The Winter Wonderland Best Ideas Virtual Investor Conference will take place on February 8th - 11th, 2022, where 36 SmallCap, MicroCap and NanoCap public companies will be presenting via virtual...
Achieve Life Sciences Announces Initiation of the Phase 3 ORCA-3 Clinical Trial Evaluating Cytisinicline for Smoking Cessation
Globe Newswire - Tue Jan 25, 2022
Globe Newswire
Tue Jan 25, 2022
SEATTLE and VANCOUVER, British Columbia, Jan. 25, 2022 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical...
Achieve Life Sciences to Present at H.C. Wainwright BIOCONNECT Virtual Conference
Globe Newswire - Thu Jan 6, 2022
Globe Newswire
Thu Jan 6, 2022
SEATTLE, Wash, Jan. 06, 2022 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the...
Achieve Life Sciences Announces Completion of Last Subject, Last Follow-Up Visit in Phase 3 ORCA-2 Trial of Cytisinicline for Smoking Cessation
Globe Newswire - Tue Jan 4, 2022
Globe Newswire
Tue Jan 4, 2022
Topline ORCA-2 Results Expected in Q2 2022...
Achieve Life Sciences Announces $25 Million Loan Facility from Silicon Valley Bank to Fund Cytisinicline Smoking Cessation Clinical Development
Globe Newswire - Wed Dec 22, 2021
Globe Newswire
Wed Dec 22, 2021
SEATTLE and VANCOUVER, British Columbia, Dec. 22, 2021 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical...
Achieve Life Sciences to Host Key Opinion Leader Panel on Smoking and e-Cigarette Cessation
Globe Newswire - Tue Nov 23, 2021
Globe Newswire
Tue Nov 23, 2021
SEATTLE, Wash and VANCOUVER, British Columbia, Nov. 23, 2021 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage...
Achieve Life Sciences Announces Phase 3 ORCA-2 Trial of Cytisinicline in Smoking Cessation Clears Final Review by Data Safety Monitoring Committee (DSMC)
Globe Newswire - Mon Nov 22, 2021
Globe Newswire
Mon Nov 22, 2021
Following the fifth and final DSMC review, committee has concluded no concerns with cytisinicline safety or Phase 3 trial conduct...
Achieve Reports Financial Results for Third Quarter 2021 and Provides Update on Cytisinicline Development
Globe Newswire - Tue Nov 9, 2021
Globe Newswire
Tue Nov 9, 2021
SEATTLE, Wash and VANCOUVER, British Columbia, Nov. 09, 2021 (GLOBE NEWSWIRE) -- -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage...